查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年生命科學分析市場中的全球人工智慧 (AI)
市場調查報告書
商品編碼
1351029

2023-2030 年生命科學分析市場中的全球人工智慧 (AI)

Global Artificial Intelligence (AI) in Life Science Analytics Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 155 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期（2023-2030 年），全球生命科學分析市場中的人工智慧將以 9.7% 的年複合成長率成長。人工智慧在醫療保健行業的日益普及預計將推動人工智慧在生命科學分析市場的成長。它涉及機器學習（ML）和深度學習過程等技術，這些技術與人工智慧一起經常被提及。藥物發現、臨床試驗、醫學診斷、患者監測和個人化醫療等生命科學分析是廣泛利用人工智慧和其他技術的關鍵領域。據國際商業機器公司稱，2022 年 3 月，全球有 35% 的公司正在使用人工智慧，42% 的公司期待將人工智慧嵌入其流程和應用中。因此，市場參與者也專注於引入基於人工智慧的解決方案，這將進一步促進市場成長。例如，2023 年5 月，Cognizant 宣布Cognizant Neuro (R) AI 是一個新的企業級平台，旨在為企業提供一種整體方法，以加快採用生成式AI 技術，並以靈活、安全、靈活的方式利用其經濟價值。可擴展且負責任的方式。

細分市場前景

全球生命科學分析市場中的人工智慧按部署、應用程式和最終用戶進行細分。根據部署，市場分為本地和雲端。根據應用，市場細分為製藥、生物技術、醫療器材和其他（個人化醫療和醫療診斷）。此外，根據最終用戶，市場細分為製藥和生物技術公司、醫療器材公司和研究中心。在最終用戶中，由於數據管理、遠端手術、診斷和程序協助、臨床試驗和基於人工智慧的醫療設備開發的成長，預計醫療設備公司細分市場將佔據相當大的市場佔有率。更多的。

研究中心細分市場預計將在生命科學分析市場的全球人工智慧中佔據相當大的佔有率

在最終用戶中，研究中心細分市場預計將佔據相當大的市場佔有率。支持市場成長的因素包括人工智慧在臨床試驗中的使用不斷增加。臨床試驗是生命科學產業數據最密集的任務之一，因為它定期產生大量數據。這鼓勵許多製藥公司和臨床研究組織投資人工智慧等技術。在目前的市場場景下，人工智慧的快速應用在製藥業得到廣泛應用，每年全球臨床試驗的近50%都在製藥業。此外，全球範圍內越來越多的臨床試驗產生了大量可在公共領域獲得的數據。在預測期內，這些數位預計將增加至少 11%，為人工智慧在臨床試驗應用中創造新的機會，特別是在歐洲和北美。

區域展望

全球生命科學分析市場中的人工智慧會根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於開發基於人工智慧的生命科學解決方案以增強產品線能力的新創公司的收購不斷增加，預計亞太地區將在全球市場中佔據顯著佔有率。

北美地區生命科學分析市場的全球人工智慧預計將以顯著的年複合成長率成長

在所有地區中，北美地區預計在預測期內將以相當大的年複合成長率成長。對人工智慧技術的需求增加、數位素養水平的提高以及生命科學分析的改進都被認為是促進該地區成長的因素。此外，各種政府措施以及私營和公共部門之間的夥伴關係的引入也顯著增加。這些策略被用來開發技術解決方案，從而推動市場成長。例如，2022 年 3 月，Databricks 為醫療保健和生命科學產業的組織推出了業界首個 Lakehouse 平台。 Databricks 的 Lakehouse for Healthcare 和 Life Sciences 為客戶提供量身定做的數據和 AI 解決方案，以應對常見的行業挑戰。

市場參與者展望

服務生命科學分析市場人工智慧的主要公司包括：埃森哲公司、亞馬遜網路服務公司、Databricks, Inc.、Indegene、IQVIA、SAS Institute Inc.、微軟公司等。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2022 年 5 月，健康管理學院 (The Academy) 與微軟子公司 Nuance 合作，為醫療保健產業提供創新的雲端和人工智慧技術。此次合作旨在圍繞市場力量以及人工智慧和機器學習的新穎發展制定一項新穎的舉措。

報告涵蓋：

  • 2022年市場價​​值數據分析及2030年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 全球生命科學分析市場人工智慧的主要公司。根據現有數據，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵細分市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Amazon Web Services, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Databricks, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Indegene
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 全球生命科學分析市場中人工智慧的部署
    • 本地部署
    • 雲
  • 全球生命科學分析市場中人工智慧的應用
    • 製藥
    • 生物技術
    • 醫療裝置
    • 其他（個人化醫療和醫療診斷）
  • 最終用戶在生命科學分析市場中的全球人工智慧
    • 製藥和生物技術公司
    • 醫療器材公司
    • 研究中心

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Accenture plc
  • Allscripts Healthcare
  • Alteryx, Inc.
  • Axtria
  • CitiusTech Inc.
  • Clarivate
  • Cognizant
  • IBM
  • Inovalon
  • Lexalytics, Inc.
  • MaxisIT
  • Microsoft Corp.
  • Optum, Inc.
  • Oracle
  • Saama Technologies, LLC
  • Sisense
  • Sorcero
  • ThoughtSpot Inc.
  • Veeva Systems Inc.
Product Code: OMR2027630

Title: Global Artificial Intelligence (AI) in Life Science Analytics Market Size, Share & Trends Analysis Report by Deployment (On-Premise, and Cloud), by Application (Pharmaceutical, Biotechnology, Medical Device, and Others), and by End-Users (Pharmaceutical and Biotechnology Companies, Medical Device Companies, and Research Centers),Forecast Period (2023-2030).

The global AI in life science analytics market is anticipated to grow at a CAGR of 9.7% during the forecast period (2023-2030). The increasing adoption of Al in healthcare industry is expected to propel the growth of Al in the life science analytics market. It involves technologies such as machine learning (ML) and deep learning processes, which are frequently mentioned along with AI. Life science analytics, such as drug discovery, clinical trials, medical diagnosis, patient monitoring, and personalized medicine are the key fields utilizing AI and other technologies extensively. According to International Business Machines Corp., in March 2022, 35% of global companies are using Al across the globe, and 42% of companies are looking forward to embedding Al in their processes and applications. Hence, the market players are also focusing on introducing AI-based solutions which will further bolster the market growth. For instance, in May 2023, Cognizant announced Cognizant Neuro® AI is a new, enterprise-wide platform created to give businesses a holistic method to quicken the adoption of generative AI technology and capitalize on its economic value in a flexible, secure, scalable, and responsible manner.

Segmental Outlook

The global AI in life science analytics market is segmented on the deployment, application, and end-users. Based on the deployment, the market is sub-segmented into on-premise and cloud. Based on the application, the market is sub-segmented into pharmaceutical, biotechnology, medical device and other (personalized medicine and medical diagnosis). Further, on the basis of end-users, the market is sub-segmented into pharmaceutical and biotechnology companies, medical device companies, and research centers. Among the end-users, the medical device company sub-segment is anticipated to hold a considerable share of the market owing to the growth in AI-based medical device development for data management, remote surgery, diagnostic and procedural assistance, clinical trials, and more.

Research Centers Sub-Segment is Anticipated to Hold a Considerable Share of the Global AI in Life Science Analytics Market

Among the end-users, research centers sub-segment is anticipated to hold a considerable share of the market. The factor supporting the market growth includes the rising use of AI in clinical trials. Clinical trials are one of the most data intensive tasks in life science industry, as it generates a huge amount of data regularly. This encourages many pharmaceutical companies and clinical research organizations to invest in technologies like artificial intelligence. In the current market scenario, the rapid adoption of AI is widely seen in the pharmaceutical sector, which is responsible for almost 50% of the clinical trials conducted globally every year. Furthermore, the increasing number of clinical trials worldwide produces colossal amounts of data available in the public domain. Over the forecast period, these numbers are expected to increase by at least 11%, creating new opportunities for AI in clinical trial applications, especially in Europe and North America.

Regional Outlook

The global AI in life science analytics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market around the globe, owing to the rising acquisitions of start-ups developing AI-based life sciences solutions to enhance the capabilities of product line.

The North America Region is Expected to Grow at a Significant CAGR in the Global AI in Life Science Analytics Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Increased demand for AI technologies, rising levels of digital literacy, and improvements in life science analytics are all suggested as factors contributing to the region's growth. Additionally, there is a considerable increase in the introduction of various government initiatives and partnerships between the private & public sectors. These strategies are being adopted to develop technical solutions, which in turn will drive the market growth. For instance, in March 2022, Databricks launched the industry's first lakehouse platform for organizations across the healthcare and life sciences industries. Databricks' Lakehouse for Healthcare and Life Sciences offers customers tailored data and AI solutions to address common industry challenges.

Market Players Outlook

The major companies serving the AI in life science analytics market include: Accenture plc, Amazon Web Services, Inc., Databricks, Inc., Indegene, IQVIA, SAS Institute Inc. Microsoft Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2022, the Health Management Academy (The Academy) partnered forces with Nuance, a Microsoft subsidiary, to offer innovative cloud and AI technologies to the healthcare industry. The partnership aims to create a novel initiative around market forces and novel developments for AI and ML.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global AI in life science analytics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Amazon Web Services, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Databricks, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Indegene
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global AI in Life Science Analytics Market by Deployment
    • 4.1.1. On-Premise
    • 4.1.2. Cloud
  • 4.2. Global AI in Life Science Analytics Market by Application
    • 4.2.1. Pharmaceutical
    • 4.2.2. Biotechnology
    • 4.2.3. Medical Device
    • 4.2.4. Other (Personalized Medicine and Medical Diagnosis)
  • 4.3. Global AI in Life Science Analytics Market by End-Users
    • 4.3.1. Pharmaceutical and Biotechnology Companies
    • 4.3.2. Medical Device Companies
    • 4.3.3. Research Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Accenture plc
  • 6.2. Allscripts Healthcare
  • 6.3. Alteryx, Inc.
  • 6.4. Axtria
  • 6.5. CitiusTech Inc.
  • 6.6. Clarivate
  • 6.7. Cognizant
  • 6.8. IBM
  • 6.9. Inovalon
  • 6.10. Lexalytics, Inc.
  • 6.11. MaxisIT
  • 6.12. Microsoft Corp.
  • 6.13. Optum, Inc.
  • 6.14. Oracle
  • 6.15. Saama Technologies, LLC
  • 6.16. Sisense
  • 6.17. Sorcero
  • 6.18. ThoughtSpot Inc.
  • 6.19. Veeva Systems Inc.

LIST OF TABLES

  • 1. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 2. GLOBAL ON-PREMISE BASED AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL CLOUD-BASED AI IN LIFE SCIENCE ANALYTICS SOLUTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR PHARMACEUTICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR MEDICAL DEVICE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 10. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN MEDICAL DEVICE COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 18. EUROPEAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 20. EUROPEAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 21. EUROPEAN AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 22. ASIA- PACIFIC AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022 VS 2030 (%)
  • 2. GLOBAL ON-PREMISE BASED AI AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL CLOUD-BASED AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
  • 5. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR PHARMACEUTICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR MEDICAL DEVICE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL AI IN LIFE SCIENCE ANALYTICS FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022 VS 2030 (%)
  • 10. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN MEDICAL DEVICE COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL AI IN LIFE SCIENCE ANALYTICS IN RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD AI IN LIFE SCIENCE ANALYTICS MARKET SIZE, 2022-2030 ($ MILLION)